Form 4: MiMedx Director Tiffany Olson Acquires 50,913 Shares

Director Tiffany Olson received an annual restricted stock grant of 50,913 shares of MiMedx Group, Inc. common stock.

Summary

• Director Tiffany Olson acquired 50,913 shares of MiMedx Group, Inc. (MDXG) common stock.
• The transaction occurred on June 10, 2026, at a price of $3.64 per share.
• The acquisition represents an annual restricted stock grant provided to non-employee directors.
• Following this transaction, the director's total beneficial ownership increased to 108,510 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Increased alignment between director interests and shareholder value through equity ownership.
• The grant is part of a standard annual compensation structure for non-employee directors.

Negatives

• None identified.

Risks

• The award is subject to vesting conditions, specifically the earlier of 12 months or the next meeting of shareholders.

Future Outlook

The restricted stock grant vests upon the earlier of 12 months from the grant date or the next meeting of shareholders.

Industry Context

StockSavvy.ai notes that annual equity grants to non-employee directors are a standard corporate governance practice in the biotechnology and medical device sectors to ensure long-term board commitment.

Comparison to Industry Standards

• The grant structure is consistent with standard equity-based compensation packages for independent directors in mid-cap healthcare companies.

Stakeholder Impact

• Increased director skin-in-the-game may be viewed positively by shareholders.

Next Steps

• Vesting of the 50,913 shares in 12 months or at the next shareholder meeting.

Key Dates

Keywords

MiMedx, MDXG, Insider Trading, Director Compensation, Form 4, Equity Grant